Biomarkers for Brain Disorders: Challenges and Opportunities

Date: 02/27/2011 to 03/02/2011

Location:
Wellcome Trust Conference Centre
Hinxton
Saffron Walden
Essex CB10 1RQ
United Kingdom

Further information: https://registration.hinxton.wellcome.ac.uk/display_info.asp...

Description: The discovery and validation of biomarkers in neurological and neurodegenerative diseases is an important challenge for early diagnosis of disease and for the development of therapeutics. This new Wellcome Trust Scientific Conference will bring together leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging and regulatory affairs. The meeting will discuss methodological aspects of biomarker identification across a spectrum of psychiatric and neurodegenerative disorders, strategies for diagnostic assay development and pathways for regulatory approval.

Contact:
Hinxton
Saffron Walden
Essex CB10 1RQ
United Kingdom
Phone: 0044 -1223 - 495100
scientificconferences@ hinxton.wellcome.ac.uk
https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=223

Organizer: Wellcome Trust

Program coordination: Andreas Jeromin, Banyab Biomarkers, USA; Andy Lockhart, GlaxoSmithKline, UK; Simon Lovestone, Kings College London, UK; William Potter, formerly Merck, Inc., USA

Keywords: research ethics; brain research; disease; medical ethics; psychiatry